ASCO 2022 Updates in HR+/HER2- eBC
Adjuvant Abemaciclib Combined With ET in HR+, HER2- High-Risk EBC: Updated Results From MonarchE
Login to view comments.
Click here to Login
ASCO 2022 Updates in HR+/HER2- eBC